The Chemours Company
CC
$12.79
$0.322.57%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.87B | 5.89B | 5.82B | 5.82B | 5.84B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.87B | 5.89B | 5.82B | 5.82B | 5.84B |
| Cost of Revenue | 4.85B | 4.81B | 4.72B | 4.67B | 4.70B |
| Gross Profit | 1.02B | 1.07B | 1.10B | 1.15B | 1.13B |
| SG&A Expenses | 603.00M | 633.00M | 607.00M | 622.00M | 556.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.56B | 5.56B | 5.44B | 5.40B | 5.37B |
| Operating Income | 312.00M | 330.00M | 388.00M | 420.00M | 468.00M |
| Income Before Tax | -201.00M | -284.00M | 46.00M | 116.00M | 38.00M |
| Income Tax Expenses | 131.00M | 140.00M | 30.00M | 42.00M | -28.00M |
| Earnings from Continuing Operations | -332.00 | -424.00 | 16.00 | 74.00 | 66.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.00M | -1.00M | -- | -- | -2.00M |
| Net Income | -333.00M | -425.00M | 16.00M | 74.00M | 64.00M |
| EBIT | 312.00M | 330.00M | 388.00M | 420.00M | 468.00M |
| EBITDA | 626.00M | 638.00M | 690.00M | 716.00M | 760.00M |
| EPS Basic | -2.22 | -2.83 | 0.11 | 0.50 | 0.43 |
| Normalized Basic EPS | 0.36 | 0.44 | 0.69 | 0.85 | 1.01 |
| EPS Diluted | -2.23 | -2.85 | 0.08 | 0.47 | 0.40 |
| Normalized Diluted EPS | 0.36 | 0.44 | 0.69 | 0.85 | 1.00 |
| Average Basic Shares Outstanding | 600.31M | 599.68M | 598.86M | 597.97M | 597.01M |
| Average Diluted Shares Outstanding | 600.77M | 599.68M | 599.57M | 599.70M | 598.73M |
| Dividend Per Share | 0.68 | 0.84 | 1.00 | 1.00 | 1.00 |
| Payout Ratio | -29.73% | -29.18% | 925.00% | 200.00% | 232.81% |